Why the study?
Does concurrent use of cisapride and CYP3A4 inhibitors increase the risk of cardiac arrhythmias in pediatric patients?
Does concurrent use of cisapride and CYP3A4 inhibitors increase the risk of cardiac arrhythmias in pediatric patients?
Answers are grounded in this paper and cite their sources.
Cisapride should be used with extreme caution, if at all, in combination with macrolides or azole antifungals due to the risk of potentially fatal cardiac arrhythmias.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Robert J. Shulman (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: